Conference Sponsors

The platform currently supports the creation of Clinical Study Reports (CSRs), lay summaries, informed consent forms (ICFs), and patient narratives. By automating structured, data-intensive components of these documents, TriloDocs dramatically reduces production timelines while maintaining regulatory compliance and quality standards.

At its core, TriloDocs integrates symbolic, rule-based AI with specialised medical writing AI agents to deliver deterministic, traceable, and audit-ready outputs – an essential requirement in GxP environments. Features such as automated signal identification, accurate processing of source data tables, and user-guided draft generation ensure compliance and consistency are embedded from the first draft.

Additional document types, including Investigator’s Brochures (IBs) and Module 2 summaries, are currently on the product roadmap.

By handling repetitive and data-heavy tasks, TriloDocs enables medical writers to focus on clinical interpretation, scientific clarity, and strategic messaging rather than manual rework. The result is faster delivery, reduced QC burden, enhanced accuracy, and improved inspection readiness.

Trusted by senior medical writers, clinical researchers, and leaders at major pharmaceutical companies and top CROs, TriloDocs positions itself as a responsible, writer-centric AI partner for the future of regulated medical writing.

AlphaLife Sciences is revolutionizing the intersection of life sciences and advanced computer science with AuroraPrime, our premier GenAI-powered SaaS platform for clinical research. Our state-of-the-art GenAI-driven medical writing solutions are trusted by leading pharmaceutical companies to enhance precision, streamline workflows, and accelerate drug development.

Supported by industry leaders such as Microsoft for Startups (Pegasus Program), Google for Startups, Johnson & Johnson Innovation – JLABS, and the Nvidia Inception Program, we leverage cutting-edge GenAI, cloud computing, and robust data platforms to transform clinical trials. Our technology automates complex processes, reduces time-to-market, and delivers unmatched efficiency, providing strategic advantages to big pharma companies.

Partner with AlphaLife Sciences to harness the full potential of GenAI and drive unparalleled innovation and success in your pharmaceutical endeavors.

Transforming drug discovery and development for good requires new levels of speed, innovation, and efficiency.  Certara is at the forefront of this evolution. Through predictive simulation, data-driven modeling, and AI tailored for drug development, Certara empowers biopharmaceutical companies to make smarter, faster decisions and bring therapies to patients with greater confidence.

As part of this vision, Certara’s regulatory science and regulatory writing services translate complex scientific data into clear, compliant, and compelling submissions. By integrating regulatory writing with strategic expertise, global regulatory knowledge, and quantitative approaches such as model-informed drug development, Certara ensures that every document supports a cohesive and persuasive regulatory narrative.

From early-stage development through post-marketing, Certara helps organizations navigate evolving global requirements, streamline submission processes, and reduce risk. Its multidisciplinary teams, combining writers, scientists, and regulatory strategists, deliver high-quality documents aligned with health authority expectations, enabling efficient pathways to approval.

With a bold vision to transform development, Certara partners with clients to turn scientific innovation into successful regulatory outcomes worldwide.

At Alexion, AstraZeneca Rare Disease pioneering in science is in our DNA. We innovate on behalf of patients and families with unmet need and follow the science to deliver life-changing medicines. We do this because the challenge of rare disease is enormous, and the patient need is high. Of the 10,000 known rare diseases, 90% do not have an approved treatment.¹

We have more than 30 years of rare disease leadership and 20-plus years of real-world evidence.

Today, this has resulted in 7 approved medicines across 8 rare diseases.

With one of the most robust early to late-stage research pipelines in rare disease, we aim to deliver five (5) new medicines by 2030. We are expanding our leadership in rare disease with multiple Phase III trials underway across disease areas, including rare haematology, nephrology, neurology, bone metabolism, cardiology, endocrinology and rare tumours.

1.Global Genes. Rare Disease Facts [Internet]. Aliso Viejo (CA): Global Genes; [cited 2026 Apr 30]. Available from: https://globalgenes.org/rare-disease-facts/

Alexion, AstraZeneca Rare Disease has designed and developed, in partnership with UPF Barcelona School of Management, a Master’s Degree in Medical Communication for the Pharmaceutical and Healthcare Industry which aims at preparing professionals to lead at the intersection of science, communication, and strategy.

Scan the QR code to learn about the Master’s Degree in Medical Communication for the Pharmaceutical and HealthCare Industry.

If you work on high-stakes documents, you’ll know that consistency isn’t a “nice to have”. That’s exactly what PerfectIt is built for.

Consistent documents, less manual checking

PerfectIt is widely used across regulated and technical environments to help teams improve style consistency, compliance with internal standards, and document readiness, while freeing editors to focus on higher-value work such as structure, meaning, logic, and reader experience.

Secure by design (no AI, no internet connection)

PerfectIt is highly secure. It isn’t AI, and it doesn’t connect to the internet. Nothing is stored, uploaded, or shared anywhere, so it’s a safe choice for confidential documents and regulated content.

Built for Word and PowerPoint teams

PerfectIt is a professional proofreading and consistency-checking tool used in Microsoft Word and PowerPoint by medical writers, editors, and document teams who need accuracy, consistency, and defensible quality control in high-stakes documents.

Unlike spelling and grammar checkers, PerfectIt focuses on the kinds of issues that editorial teams spend disproportionate time hunting down manually, including inconsistencies in style, terminology, abbreviations, capitalization, hyphenation, numbers, and formatting conventions. It’s designed for organizations working with formal style guides, lexicons, and controlled language rules, where consistency matters and deviations create risk, rework, and reviewer friction.

Enforce style rules automatically

A key capability is the use of a PerfectIt Style Sheet, which allows organizations to load their in-house style guide and preferred terminology into PerfectIt so it can automatically check documents against those conventions. Teams can apply house rules consistently across documents, authors, and projects, without relying solely on memory or individual editorial judgment.

Automation with human control

PerfectIt supports a modern quality workflow where automation reinforces editorial standards, while the final decision stays with the human reviewer. Writers and editors can run PerfectIt strategically, often once drafting and manual quality checks are complete, to catch issues that are easily missed due to human error.

Emtex Life Science offers worldwide professional medical writing and related services to the pharmaceutical (human & veterinary), biotech, medical device and other industries, CROs and academic institutions.

With over 25 years of experience in the field, we guarantee the best possible medical writing and related services.

Over the years, we have gained extensive experience in the presentation and interpretation of data into well-structured, clear scientific documents. Emtex has contributed to several successful submission dossiers.

We can support your company in the preparation of the documentation needed to speed up the development processes on the way to regulatory submission and approval.

Emtex Academy: https://www.emtexacademy.com/

Our professionals have developed several training sessions related to diverse topics and/or skills for medical writers. We can also provide tailor-made courses for medical writers, designed to meet your specific needs/requirements.

Together with you, we determine the content, duration, delivery format, and other requirements of the course. Based on this input, our experts develop the desired tailor-made course. It can take place in our facilities, your company, other location, or even online. Our trainers are professionals with sufficient experience in the field.

Trilogy is a trusted partner for end-to-end regulatory support. From medical writing to publishing, submissions management, regulatory strategy/intelligence, disclosure and transparency, labelling, artwork, and plain language – we integrate these services seamlessly to create efficiencies and synergies for our clients. All strengthened by technology, AI-enabled platforms and digital innovation. For over 20 years, we have helped pharmaceutical and biotech companies to streamline documentation processes, ensuring clarity, compliance, and timely delivery. Our holistic approach across regulatory services means fewer handoffs, better coordination, and documents that accelerate review and approval – all leading to faster delivery of medical treatments to patients.